Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects
Akiko Sarashina, Shogo Sesoko, Mitsuyoshi Nakashima, Naoyuki Hayashi, Atsushi Taniguchi, Yoshiharu Horie, Eva U. Graefe-Mody, Hans-Juergen Woerle, Klaus A. DugiVolume:
32
Year:
2010
Language:
english
Pages:
17
DOI:
10.1016/j.clinthera.2010.06.004
File:
PDF, 212 KB
english, 2010